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Randomised controlled trialAnxiety and depression are prevalent among university students and many universities offer psychological ser-
vices to assist students. Unfortunately, students can experience barriers that prevent access to these services and
many university services experience difﬁculties meeting demand. The present pragmatic randomised controlled
trial examined the preliminary efﬁcacy and acceptability of a transdiagnostic and internet-delivered cognitive
behavioural therapy (CBT) programme for university students seeking help with anxiety and depression. Partic-
ipants were randomly allocated to either a treatment group (n= 30) or a waitlist-control group (n= 23). The
treatment group received weekly contact with a therapist, via telephone or a secure messaging system, as well
as automated emails that guided their progress through the programme. Signiﬁcant reductions were found on
standard measures of anxiety (Cohen's d= 0.66; 95% CI: 0.13 to 1.17) and depression (Cohen's d= 0.81; 95%
CI: 0.27 to 1.32) among the treatment group participants, but no signiﬁcant differences were found between
the treatment and control groups at post-treatment. However, more pronounced reductions were found
among treatment group participants with clinical level symptoms of anxiety (Cohen's d= 1.33; 95% CI: 0.62 to
1.99) and depression (Cohen's d= 1.59; 95% CI: 0.81 to 2.30), who reported signiﬁcantly lower levels of symp-
toms than control groupparticipants at post-treatment. These reductionsweremaintained at 3-month follow-up
and participants rated the intervention as acceptable. The results provide preliminary support for the potential of
iCBT for university students with anxiety and depression. However, larger scale implementation trials consider-
ing a broader range of outcomes are required.ent of Psychology, Macquarie
9979; fax: +61 2 9850 8062.
. This is an open access article under the CC BY-NC-ND licTrial registration: Australian and New Zealand Clinical Trials
Registry: ACTRN12612000212853.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Psychological distress among university students is signiﬁcantly
higher than the general population (Stallman, 2010) and the prevalence
ofmental health difﬁculties among university students appears to be in-
creasing (Storrie et al., 2010). However, research indicates that the
utilisation rates for student counselling and psychological services is
very low (Raunic and Xenos, 2008) with many students avoiding or
delaying access (Eisenberg et al., 2007; Stallman, 2010; Storrie et al.,
2010). The barriers to accessing treatment among university studentsare similar to the general population and include stigma, long wait-
times and a preference to seek help from family, friends and the internet
(Brimstone et al., 2007; Lui et al., 2014; Rickwood et al., 2007; Ryan
et al., 2010). A challenge facing university counselling services is how
to reduce these barriers while providing access to evidence-based
treatment in a cost-effective way.
There is now considerable evidence for the efﬁcacy of cognitive be-
havioural therapy (CBT) in the treatment of anxiety and depression
(Butler et al., 2006; Cuijpers et al., 2008; Stewart and Chambless,
2009) and a growing recognition of the need for innovative models of
service delivery that increase both access to treatment and the capacity
of treatment services (Kazdin and Blasé, 2011; Kazdin, 2015). Over the
last decade, there has been increasing interest in the potential of
internet-delivery of CBT (iCBT) as an approach for increasing access toense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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is now strong meta-analytic support for the efﬁcacy of iCBT for anxiety
and depression over control conditions (Andersson and Cuijpers,
2009; Cuijpers et al., 2009). There is also emerging evidence of the com-
parability of clinical outcomes between face-to-face and internet-
delivered CBT (Cuijpers et al., 2010) as well as the cost-effectiveness
of iCBT (Hedman et al., 2012). iCBT interventions provide the same
information and teach the same skills as traditional face-to-face CBT,
but provide this information via structured materials accessible by
computer and the internet. Internet-delivered treatments can be
clinician-guided, coach-guided or entirely self-guided, with most
approaches involving a fraction of the time required by traditional
face-to-face psychological treatments (Andersson and Titov, 2014;
Hedman et al., 2012).
Despite their potential only a limited number of randomised
controlled trials have examined the use of iCBTwith university students
(Cukrowicz and Joiner, 2007; Day et al., 2013; Ellis et al., 2011; Kenardy
et al., 2003; Lintvedt et al., 2011;Mitchell and Dunn, 2007; Orbach et al.,
2007; Santucci et al., 2014; Sethi et al., 2010) and a recentmeta-analysis
found that, although such interventions can be beneﬁcial, some caution
is needed when interpreting the results of existing studies because of
important methodological issues (Davies et al., 2014). For example,
one of these studies (n= 83) examined a self-guided 6-week anxiety
prevention programme for studentswith high levels of anxiety sensitiv-
ity and found reductions in anxiety-related cognitions and symptoms of
depression, but not anxiety sensitivity, comparedwith awaitlist-control
group (Kenardy et al., 2003). However, the studywas limited by the use
of a convenience sample of ﬁrst year psychology students rather than
students presenting or requesting assistance for mental health difﬁcul-
ties and did not include any follow-up assessment. Other studies have
examined the feasibility of the established Beating the Blues Programme
(n = 10; Mitchell and Dunn, 2007) and compared the efﬁcacy of this
programme provided with and without email reminders (n = 57;
Santucci et al., 2014). Both studies reported improvements in depres-
sion scores, however, one study reported very low treatment comple-
tion rates (i.e., b20%) (Santucci et al., 2014) and neither study
included parallel control groups. Thus, while the ﬁndings of existing
studies are encouraging, there is still relatively limited empirical data
and more research is required concerning the efﬁcacy and acceptability
of iCBT for university students.
The present study examined the efﬁcacy and acceptability of a new
iCBT programme, the UniWellbeing Course, for university students
experiencing symptoms of stress, anxiety, low mood and depression.
The intervention is delivered with weekly support from a clinician and
is designed to be appropriate for students with subclinical as well
as clinical symptoms of anxiety and depression. Using a two-group
randomised controlled trial (RCT) design, it was hypothesised that:
(1) the treatment group would report signiﬁcantly reduced symptoms
of anxiety and depression at post-treatment compared with the
waitlist-control group, (2) that treatment group participants with clini-
cal level symptoms would report reductions in symptoms of anxiety
and depression consistent with those observed in previous iCBT studies,
and that (3) symptom reductions would be sustained at 3-month
follow-up and participants would be satisﬁed with the treatment. The
present study was setup as a pragmatic RCT and, consequently, several
modiﬁcations to the length and number of lessons in the programme
were made during the trial, based on participant feedback, in order to
maximise the acceptability of the intervention.
2. Method
2.1. Participants
Participants were students attending Macquarie University, Sydney,
Australia,who applied to participate via thewebsite of the eCentreClinic
(www.ecentreclinic.org); a specialist research clinic at the university,which provides online treatment for commonmental health conditions.
The UniWellbeing Course was promoted across the university campus
via social and print media and via the University's Campus Wellbeing
Service, which offers psychological support and treatment services to
students. All advertisements targeted psychologically distressed
students who were interested in psychological treatment; however,
students did not have to attend or have an initial assessment with the
University's Campus Wellbeing Service in order to participate. The
participants were offered the opportunity to enter a draw to win an
iPad for participating in the study and completing the post-treatment
and follow-up questionnaires.
A total of 95 participants applied to participate in the study and 63
met the full inclusion and exclusion criteria. The inclusion criteria
were as follows: (1) currently living in Australia; (2) 18 years of age
or older; (3) self-identiﬁed as experiencing symptoms of anxiety or de-
pression; and (4) access to a computer, the internet and use of a printer.
The exclusion criteria were as follows: (1) currently participating in
CBT; (2) currently experiencing a psychotic mental illness or severe
symptoms of depression (deﬁned as a total score N19 or responding
N2 to Question nine (suicidal ideation) on the Patient Health
Questionnaire-9 Item (PHQ-9; Kroenke et al., 2001); and (3) not on a
stable dose of medication for at least 1 month, if taking medication for
anxiety or depression.
Interested students were invited to complete an online application
and questionnaires. Applicants were contacted via telephone to conﬁrm
that theymet the study's criteria and to complete a diagnostic interview
using the Mini International Neuropsychiatric Interview 5.0.0 (MINI:
Sheehan et al., 1998). Fifty-ﬁve applicants met all the criteria and
were randomised using a true randomisation process (www.random.
org) to either the treatment (n = 31) or the waitlist-control group
(n = 24). One participant in the treatment group withdrew before
starting treatment and their data was not analysed. One participant in
the waitlist-control group was hearing impaired and unable to com-
plete the telephone interview, but was included in the study and the
analysis. The demographic and diagnostic characteristics of the sample
are shown in Table 1 and the details of the participant ﬂow are included
in Fig. 1.
2.2. Design
Thedesign comprised a CONSORT-revised compliant RCT comparing
an immediate treatment group with a delayed-treatment waitlist-
control group. The outcome measures were administered at pre-
treatment, weekly during the course and at post-treatment. The treat-
ment group also completed questionnaires 3 months after ﬁnishing
the course. All questionnaires were administered online, which is con-
sidered as reliable as paper-and-pencil administration (Carlbring et al.,
2007; Donker et al., 2010; Hedman et al., 2010). The MINI diagnostic
assessments were conducted at initial application.
Power calculations using G*Power (Faul et al., 2007) indicated that
26 participants in each group were sufﬁcient to detect a between-
groups effect size of 0.7, with alpha set at 0.05 and power set at 0.80,
which was the minimum based on similar studies at the time (Dear
et al., 2011a; Titov et al., 2011a). Ethical approval for the trial was pro-
vided by the Human Research Ethics Committee of Macquarie Universi-
ty and the trial was registered on the ANZCTR trial registry as
ACTRN12612000212853.
2.3. Measures
2.3.1. Patient Health Questionnaire-9 item (PHQ-9; Kroenke et al., 2001)
The PHQ-9 is a nine-item measure of the symptoms and severity of
major depressive disorder based on DSM-IV criteria. A total score of
≥10 on the PHQ-9 has been identiﬁed as a reliable indicator for a
probable diagnosis of a depressive disorder (Kroenke et al., 2001).
Psychometric studies indicate high levels of consistency (e.g., N .80)
Table 1
Demographic and diagnostic characteristics of the treatment and control groups.
Variable Treatment
group
Control
group
Signiﬁcance statistics
n % n %
Gender
Male 11 36.7% 8 34.8% χ2 = 0.02, p= .89
Female 19 63.3% 15 65.2%
Age
Mean 28.6
(SD: 10.05)
26.9
(SD: 11.51)
F= 0.49, p= .62
Range 19 to 55 19 to 55
Marital status
Single/never married/widowed 24 80.0% 13 56.5% χ2 = 3.40, p= .07
Married/de facto 6 20.0% 10 43.5%
Student status
Full-time 22 73.3% 17 73.9% χ2 = 0.03, p= .87
Part-time 7 23.3% 6 26.1%
Type of degree programme
Undergraduate 25 83.3% 15 65.2% χ2 = 3.18, p= .07
Postgraduate 4 13.3% 8 34.8%
Diagnostic data (at assessment)
MINI-diagnosis at assessment
Generalised anxiety disorder 27 90.0% 13 56.5% χ2 = 6.83, p= .01
Panic disorder 8 26.7% 4 17.4% χ2 = 0.52, p= .35
Social anxiety disorder 13 43.3% 6 26.1% χ2 = 1.41, p= .19
Major depressive episode 13 43.3% 5 21.7% χ2 = 2.38, p= .11
Number of diagnoses
0 2 6.7% 6 26.1% –
1 9 30.0% 9 39.1% –
2 8 26.7% 4 17.4% –
≥3 11 36.7% 3 13.0% –
Mean number diagnoses 2.03
(SD: 1.12)
1.27
(SD: 1.20)
F= 2.33. p= .02
Note. Technical issues prevented the data for student status and degree programme for
one participant. One participant was unable to participate in the diagnostic interview
due to a hearing impairment.
MINI; mini international neuropsychiatric interview.
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Titov et al., 2011b). Cronbach's alpha in the present study was .82.
2.3.2. Generalized Anxiety Disorder-7 item scale (GAD-7; Spitzer et al.,
2006)
The GAD-7 comprises 7 items measuring symptoms and severity of
GAD based on the DSM-IV diagnostic criteria for GAD. The GAD-7 has
high internal consistency and test–retest reliability as well as showing
good convergent validity with other anxiety scales (Dear et al., 2011b;
Kroenke et al., 2010; Spitzer et al., 2006;). Evidence indicates that the
GAD-7 is sensitive toDSM-IV congruent GAD, social phobia and panic dis-
order with increasing scores indicating greater severity of symptoms
(Löwe et al., 2008). A total score of≥8 on the GAD-7 has been identiﬁed
as a reliable indicator of a probable diagnosis of an anxiety disorder
(Löwe et al., 2008). The GAD-7 is increasingly used in research and in
large scale dissemination studies as a generic measure of change in anx-
iety symptoms (Richards and Suckling, 2009; Titov et al., in press).
Cronbach's alpha in the current study was .88.
2.3.3. Kessler-10 item (K-10; Kessler et al., 2002)
The K-10 is a 10-item measure of general psychological distress.
There is strong evidence supporting the relationship between the
K-10 and psychological distress with total scores of ≥22 associated
with a diagnosis of an anxiety and depressive disorder (Andrews and
Slade, 2001). Cronbach's alpha in the current study was .85.
2.3.4. Sheehan Disability Scales (SDS; Sheehan, 1983)
The SDS is a 3-itemmeasure of disability with scores ranging from 0
to 30 and well established psychometric properties (Leon et al., 1997).
Cronbach's alpha in the current study was .84.2.3.5. Mini International Neuropsychiatric Interview version 5.0.0 (MINI;
Sheehan et al., 1998)
The MINI is a brief diagnostic interview developed to determine the
presence of current Axis-I disorders using DSM-IV diagnostic criteria. It
has excellent inter-rater reliability (k = 0.88–1.00) and adequate
concurrent validity with the Composite International Diagnostic
Interview (World Health Organization, 1990).
2.4. Intervention
The UniWellbeing Course is a new psychological intervention, based
on previously developed internet-delivered transdiagnostic interven-
tions for anxiety and depression (Dear et al., 2011a; Titov et al.,
2011a; Titov et al., 2013, 2014). The UniWellbeing Course is based on
the principles of CBT and systematically teaches information and core
psychological skills that help people to understand their experiences
of anxiety and depression and to start to manage their symptoms. The
UniWellbeing Course comprises materials presented in a didactic form
(i.e., text-based instructions and information) combined with case-
enhanced learning examples (i.e., detailed case studies). Case-
enhanced learning uses educational stories that identify a problem
and a solution that a case study resolves for the learner, which is
thought to facilitate learning and engagement while reducing appre-
hension (Titov et al., 2013, 2014). The primary difference between the
UniWellbeing Course and previously developed courses was that the
latterwasmodiﬁed to be appropriate for a cohort of university students.
For example, the existing images were replaced with those depicting
students and younger adults and case stories and examples were used
which focussed on and scenarios relevant to university students were
employed (e.g., stresses and pressures around exams, assignments,
and navigating the transition to university life).
The UniWellbeing Course was delivered over four phases. The core
lessons provided key psychological information and taught core psy-
chological skills. Each lesson was accompanied by a Do-It-Yourself
Guide summarising the relevant lesson and suggesting practice activi-
ties to help participants learn and use the skills. Each lesson was also
supplemented with several detailed case stories and additional re-
sources, which covered areas such asmanaging sleep, solving problems,
managing irrational beliefs, controlling worry and assertive communi-
cation. Because one of the aims of the present trial was to determine
the most suitable course format for participants, changes to the struc-
ture and duration of the UniWellbeing Course were made during the
trial. Speciﬁcally, the ﬁrst phase (n = 6) received a 3-lesson version
(i.e., each lesson comprising 52 to 63 slides) of the Course, in which
the lessons were systematically released, fortnightly, over 6 weeks.
Then, in the second and third phases (n= 15), the coursewasmodiﬁed
into a 6-lesson course (i.e., each lesson comprising 99 to 120 slides)
with 1 short lesson released systematically, over 6 weeks. Finally,
in the fourth phase (n = 9), the materials were modiﬁed to form a 5-
lesson course (i.e., each lesson comprising 52 to 63 slides) delivered
over 5 weeks. Importantly, the therapeutic content and core psycholog-
ical skills taught remained the same across the different formats; differ-
ences in the number of lessons and slides across formats reﬂected
differences in theway inwhich informationwaspresented andwhether
content was presented as part of a lesson or in an additional resource.
For example, in the 3 lesson version of the course two or three core skills
were often taught in one lesson (i.e., making the lessons longer) where-
as in the 5 lesson version one or two skills were taught (i.e., making the
lessons shorter) with more materials being provided as additional re-
sources. The content of the 5-lesson version and additional resources
are described in Table 2.
2.5. Therapist contact
One therapist, a provisionally registered psychologist (AM) under-
taking doctoral studies in psychology provided all clinical contact with
Fig. 1. Participant ﬂow chart.
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Authors BFD and NT provided weekly, 1 hour supervision sessions at a
scheduled time in which all cases were reviewed. Supervision wasTable 2
UniWellbeing course lesson content.
Lesson Core lesson content Additional resources
1 Education about the prevalence, symptoms and
treatment of anxiety. Introduction of a CBT
model and explanation of the functional
relationship between physical, cognitive and
behavioural symptoms. Instructions for
identifying one's own symptoms and how the
symptoms interact.
– What to do in a
mental health
emergency
2 Introduction to the basic principles of cognitive
therapy and importance of managing thoughts
to managing anxiety. Instructions for
monitoring and challenging automatic
thoughts.
– Sleep management
– Structured problem
solving
3 Introduction to the physical symptoms of
anxiety (i.e. hyper-arousal) and depression
(i.e., hypo-arousal) and their relationship to
emotional wellbeing. Instructions about con-
trolling physical symptoms using strategies
such as controlled breathing and scheduling
pleasant activities.
– Worry time
– Challenging irrational
beliefs
– Managing panic
attacks
4 Introduction to the behavioural symptoms of
anxiety (i.e., safety behaviours and avoidance
behaviours). Instructions about behavioural ac-
tivation and graded exposure.
– A list of 100 pleasant
things to do
– Overcoming
procrastination
5 Information about the occurrence of lapses and
managing long-term wellbeing. Information
about the signs of relapse and instructions for
creating a relapse prevention plan.
– Assertive
communication skillsprovided at other times as required. The therapist attempted to contact
participants each week during the course and tried to limit contact to 5
to 10 minutes, although more time could be used where clinically indi-
cated. The participants could elect to have their weekly contact via tele-
phone or the secure email-type system. The aim of the contact was to
reinforce progress, describe and summarise key skills, encourage prac-
tice and lesson completion, and normalise challenges. The participants
were invited to engage in discussions of the materials and to provide
feedback about thematerial to the clinician. All contactswith the partic-
ipants were recorded as was the total therapist time spent per partici-
pant. Automated emails were also sent to participants at speciﬁc times
during treatment to notify them of new resources that had become
available or to encourage them to complete the tasks.
2.6. Statistical analysis
All analyses were conducted using SPSS version 22. Group differ-
ences in demographic and diagnostic data were analysed with one-
way analyses of variance (ANOVAs) and chi-square tests (Table 1).
A generalised estimation model (GEE) modelling technique was
employed to examine changes in PHQ-9 GAD-7, K-10 and SDS scores.
GEE emphasises themodelling of an average group (i.e., population) ef-
fect over time, where the within subjects variance can be accounted for
in the model estimates, but with a primary emphasis on the average
group-related change over time (Hubbard et al., 2010). An exchange-
able working correlation structure was selected, coupled with a robust
error estimation for the purposes of model parsimony, for all GEE
analyses. All GEE models also speciﬁed a gamma distribution with a
log link response scale to address positive skewness in the dependent
variable distributions. Consistent with the principles of intention-to-
treat analyses GEE analyses were ﬁrst run to imputemissing data points
132 A. Mullin et al. / Internet Interventions 2 (2015) 128–136for participants with missing data using initial scores as a covariate.
Time and Group were speciﬁed as predictor variables, with time as a
within-subject variable, and the response or dependent variable as the
outcome variable. Consistent with previous clinical trials (e.g., Dear
et al., 2015; Titov et al., 2015) and large dissemination studies of
transdiagnostic treatments (Richards and Suckling, 2009; Gyani et al.,
2013; Titov et al., in press), the primary GEE analyses were then run
separately for the overall sample and for the clinical subsamples,
which comprised those participants scoring ≥8 on the GAD-7 at pre-
treatment or ≥10 on the PHQ-9 at pre-treatment. Importantly, com-
paredwith the overall analyses, the clinical subsample analyses provide
outcome data focussed on those individuals whowould be identiﬁed as
having clinical-level difﬁculties in the outcome areas. These analyses
acknowledge the heterogeneity of presentations in transdiagnostic
treatments and recognise that not all individuals have clinical level
difﬁculties in each outcome domain. Effect sizes (Cohen's d) and 95%
conﬁdence intervals were also calculated for both within-group and
between-group effects based on the estimated means and pooled SDs,
which were calculated from the estimated SEs.
The following criteria of clinical signiﬁcance were used. First, reliable
improvementwas calculated using standard procedures for determining
reliable change (Jacobson and Truax, 1991),which take into account the
reliability and measurement error associated with the questionnaire
being employed. Speciﬁcally, a person was deemed to have made a
reliable improvement if they scored above the total cut-off at pre-
treatment (i.e.,≥8 on the GAD-7 or≥10 on the PHQ-9) and their symp-
toms improved by a reliable amount; that is, more than 3.53 or 5.20 on
the GAD-7 and the PHQ-9, respectively (Gyani et al., 2013). Second, re-
liable recoverywas determined to have occurred if a participant scored
above the clinical cut-off at pre-treatment, made a reliable improvement,
and scored below the clinical cut-off at the post-treatment or follow-up
timepoint of interest. Finally, a personwas deemed to have a reliable de-
terioration if their symptoms deteriorated or worsened by a reliable
amount; that is, more than 3.53 or 5.20 on the GAD-7 and the PHQ-9,
respectively (Gyani et al., 2013).
3. Results
3.1. Preliminary tests
No differences were found between the treatment and control
groups on the demographic variables shown in Table 1. However, the
treatment group met the diagnostic criteria for a greater number of
diagnoses at assessment compared to the control group. No differences
were found between the treatment and control groups at pre-treatment
on PHQ-9, GAD-7, K-10 or SDS scores (ps N .05).
3.2. Symptom outcomes for overall sample
The means, standard deviations and effect sizes for the outcome
measures are shown in Table 3. Themeans and 95% conﬁdence intervals
for the outcome measures are shown in Fig. 2. The GEE analyses
revealed signiﬁcant effects for Time (PHQ-9: Wald's χ2 = 76.69,
p b .001; GAD-7: Wald's χ2 = 39.89, p b .001; K-10: Wald's χ2 =
81.30, p b .001; SDS: Wald's χ2 = 49.62, p b .001) and a signiﬁcant
Time by Group interaction on the PHQ-9 (Wald's χ2 = 9.04, p b .01),
GAD-7 (Wald's χ2 = 14.09, p b .001), and SDS (Wald's χ2 = 5.64,
p= .018), but not the K-10 (Wald'sχ2= 2.53, p= .112). Pairwise com-
parisons showed no signiﬁcant differences between groups post-
treatment for the PHQ-9 (p = .172) or SDS (p = .328). However,
there was a difference at post-treatment on the GAD-7 (p = .042)
with the treatment group reporting lower scores. Pairwise comparisons
also revealed that the treatment group reported signiﬁcant improve-
ments in scores from pre-treatment to post-treatment (p ≤ .001) on
the PHQ-9, GAD-7 and SDS, where the control group did not report
any improvements from pre-treatment to post-treatment (p range =.168 to .758). The comparisons also revealed signiﬁcant further
improvements frompost-treatment to 3-month follow-up for the treat-
ment group on the PHQ-9, GAD-7 and SDS (ps ≤ .001).
3.3. Symptom outcomes for clinical subsamples
The means, standard deviations and effect sizes for the clinical sub-
samples are shown in Table 3 and the means and 95% conﬁdence inter-
vals for the outcome measures are shown in Fig. 2. GEE analyses
revealed signiﬁcant effects on the PHQ-9 for Time (Wald's χ2 = 70.39,
p b .001) and a signiﬁcant Time by Group interaction (Wald's χ2 =
8.01, p = .005). Pairwise comparisons revealed a signiﬁcant between
group difference at post-treatment (p = .030) with the treatment
group reporting fewer symptoms. These comparisons also revealed
the treatment group's symptoms reduced from pre-treatment to post-
treatment (p b .001) and from post-treatment to 3-month follow-up
(p b .001), but there were no reductions in the control group's symp-
toms from pre-treatment to post-treatment (p= .353).
TheGEE analyses also revealed signiﬁcantmain effects on theGAD-7
for Time (Wald's χ2 = 38.70, p b .001) and Time by Group interaction
(Wald's χ2 = 34.45, p b .001). Pairwise comparisons revealed a signiﬁ-
cant difference between groups at post-treatment (p b .001) with the
treatment group reporting fewer symptoms. Treatment group scores
also improved from pre-treatment to post-treatment (p b .001) and
from post-treatment to-3 month follow-up (p = .010), while the
control group's symptoms worsened from pre-treatment to post-
treatment (p= .02).
3.4. Clinical signiﬁcance
The proportions of participants reporting reliable improvement,
reliable recovery and reliable deterioration are shown in Table 4. Chi-
square analyses indicated greater proportions of reliable improvement
and reliable recovery on the GAD-7 in the treatment group compared
to the waitlist-control group (p b .05). No signiﬁcant differences were
found in the levels of reliable improvement and reliable recovery in the
treatment and control groups; however, the levels of both appeared to
increase in the treatment group at the 3-month follow-up time point.
For example, at 3-month follow-up, approximately 45% of the treatment
group reported reliable improvement and reliable recovery on the GAD-7
and the PHQ-9.
3.5. Clinical contact
The mean clinical contact time per participant in the treatment
group was 19.21 minutes (SD = 15.16), which included reading and
sending secure email messages and telephoning participants. During
the course the clinician sent a total of 75messages (M= 2.6 per partic-
ipant) and made 69 telephone contacts (M = 2.4 per participant). An
additional 60 minutes was required per participant to complete the
MINI diagnostic assessments and for general administrative purposes.
3.6. Treatment completion and treatment satisfaction
Forty-three percent of the treatment group participants completed
the entire course within 6 weeks. At post-treatment, participants were
invited to provide evaluative feedback about the intervention,which in-
volved answering several open-ended questions and rating the course
on a 5 point scale ranging fromvery satisﬁed to very dissatisﬁed. Sixteen
participants in the treatment groupprovided feedback about the course.
Technical issues prevented 3 participants from providing feedback. No
reason was given by the remaining two participants. Of the participants
who did provide feedback about the course (n=16), 87.5% (14/16) in-
dicated that they were very satisﬁed or mostly satisﬁed with the course
and only 12.5% (2/16) were neutral or dissatisﬁed with the course.
Moreover, of the respondents, 93.8% (15/16) indicated it was worth
Table 3
Means, standard deviations and effect sizes (Cohen's d) for the observed and estimated marginal means for each group.
n Observed means Estimated means Effect sizes (based on estimated means)
Pre Post 3-Month
follow-up
Pre Post 3-Month
follow-up
Pre- to post-within
group effect size
Post-between
group effect
size
Pre- to 3-month
follow-up within
group effect size
Overall sample
PHQ-9
Treatment
Group
30 11.16 (5.32) 6.33 (4.59) 4.16 (3.74) 11.17 (5.24) 7.27 (4.36) 4.57 (3.15) 0.81 [0.27–1.32] 0.40 [−0.16–0.94] 1.53 [0.93–2.08]
Control Group 23 10.04 (5.35) 8.70 (6.53) – 10.04 (5.24) 9.37 (6.30) – 0.12 [−0.46–0.69] –
GAD-7
Treatment
Group
30 9.60 (5.51) 6.09 (4.01) 4.44 (3.32) 9.60 (5.43) 6.57 (3.60) 4.71 (2.73) 0.66 [0.13–1.17] 0.60 [0.04–1.15] 1.14 [0.58–1.67]
Control Group 23 8.39 (3.89) 8.35 (5.60) – 8.39 (3.81) 9.48 (6.10) – −0.21 [−0.79–0.37] –
K-10
Treatment
Group
30 24.93 (6.49) 21.14 (6.32) 17.00 (5.49) 24.93 (6.49) 21.77 (6.52) 17.47 (5.31) 0.49 [−0.03–0.99] −0.03
[−0.57–0.52]
1.26 [0.69–1.79]
Control Group 23 22.52 (6.53) 20.74 (7.21) – 22.52 (6.39) 21.60 (7.08) – 0.13 [−0.45–0.71] –
SDS
Treatment
Group
30 19.48 (9.32) 13.24 (7.47) 8.00 (6.47) 19.48 (9.32) 14.54 (7.37) 8.68 (5.53) 0.59 [0.06–1.10] 0.28 [−0.27–0.83] 1.41 [0.83–1.96]
Control Group 23 16.57 (11.10) 14.68 (10.47) – 16.57 (10.86) 17.12 (10.90) – −0.05 [−0.63–0.53] –
Clinical subsample
PHQ-9 ≥ 10
Treatment
group
20 14.10 (3.62) 8.33 (4.86) 5.60 (4.22) 14.10 (3.53) 8.98 (4.14) 5.64 (3.13) 1.33 [0.62–1.99] 0.91 2.34 [1.66–3.31]
Control group 11 14.63 (3.35) 13.37 (7.42) – 14.64 (3.20) 13.50 (6.19) – 0.23 [−0.62–1.06] [−0.12–1.66] –
GAD-7 ≥ 8
Treatment
group
18 13.33 (3.71) 6.75 (4.37) 5.10 (4.17) 13.33 (3.61) 7.51 (3.71) 5.49 (3.10) 1.59 [0.81–2.30] 1.54 2.33 [1.44–3.12]
Control group 12 11.33 (2.60) 12.66 (4.18) – 11.33 (2.49) 13.75 (4.53) – −0.66 [−1.46–0.18] [0.68–2.32] –
Note. Standard deviations are shown in round parentheses and 95% conﬁdence intervals are shown in square parentheses. GAD-7: Generalised Anxiety Disorder 7-item; PHQ-9: Patient
Health Questionnaire 9-item; K-10: Kessler 10-item; and SDS: Sheehan Disability Scales.
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they would recommend the course to others. Finally, 93% (15/16) re-
ported that they were more conﬁdent to manage symptoms of stress,
anxiety, low mood and depression as a result of the course.
4. Discussion
The aim of the present study was to examine the feasibility, accept-
ability and efﬁcacy of iCBT for university students experiencing symp-
toms of stress, anxiety, low mood and depression. It was hypothesised
that the treatment group would report signiﬁcantly reduced symptoms
of anxiety and depression at post-treatment and that participants with
clinical level symptoms would report reductions in symptoms of anxi-
ety and depression consistent with those observed in previous iCBT
studies. It was also hypothesised that symptom reductions would be
sustained at 3 months and that participants would rate the treatment
as acceptable. These hypotheses were partially supported. The treat-
ment group’s symptoms reduced at a greater rate than the control
group, but there were no signiﬁcant differences between the groups at
post-treatment with the exception of anxiety, which was signiﬁcantly
lower for the treatment than the control group. However, when focus-
sing on participants with clinical-level symptoms, these reductions
weremoremarked and evidence of signiﬁcant differences in symptoms
of anxiety and depression were found. The reductions in symptoms
were maintained at 3-month follow-up in both the overall sample and
in those participants with clinical level symptoms. There was also
some evidence of further improvement in symptoms from post-
treatment to 3-month follow-up. The treatment was rated as
acceptable and required relatively little clinician time on average per
participant.
The ﬁndings of the present study are encouraging and are largely
consistentwith the results reported in the broader literature concerning
iCBT for anxiety and depression (Andersson and Cuijpers, 2009;
Cuijpers et al., 2010). The results are also generally consistent with theprevious studies examining the use of internet-delivered psychological
treatments for university students (Day et al., 2013; Kenardy et al.,
2003; Mitchell, and Dunn, 2007; Santucci et al., 2014). For example,
one study (n=66) of a 6-week iCBT programme, supported by trained
university students, found moderate effect size (Cohen's d N 0.50) re-
ductions in anxiety and depression among treatment group participants
compared with control group participants (Day et al., 2013), which
weremaintained at 6-month follow-up. Thepresent study found similar
reductions among the overall treatment group (Cohen's d N 0.50) and,
as hypothesised, evidence of larger reductions (Cohen's d N 0.80)
among participantswith clinical-level symptoms of anxiety and depres-
sion. Importantly, although the treatment group participants exhibited
signiﬁcantly greater reductions in symptoms over time, evidence of
between group differences in symptoms at post-treatment were only
found for the clinical subsamples. This likely reﬂects the small sample
sizes employed in the present study as well as the relatively low
symptom levels reported by many participants.
The present study is encouraging in termsof the preliminary support
it provides for the feasibility and acceptability of iCBT provided to stu-
dents. For example, more than 85% of the participants that provided
feedback indicated that they were satisﬁed or very satisﬁed with the
course. It is worthwhile to note that these levels of satisfaction were
obtained with relatively little clinician contact per participant
(M = 19.21 min; SD = 15.16), which highlights the potential cost-
effectiveness of iCBT treatments and the potential of iCBT to university
student counselling services. It is also important to note that the overall
completion rate of approximately 45% in the present studywas low com-
pared with other similar clinician-guided iCBT programmes for adults
with anxiety and depression generally (e.g., Dear et al., 2011a). However,
the completion rates are consistentwith those observed in previous stud-
ies of university students (61%: Day et al., 2013) and other studies of iCBT
provided to younger adults (61%; Johnston et al., 2014). Adherence helps
to ensure that the participants obtain a sufﬁcient ‘therapeutic dose’ and
the present study was pragmatic in that aim to explore the most suitable
Fig. 2.Means and 95% conﬁdence intervals for the groups across the treatment time points.
134 A. Mullin et al. / Internet Interventions 2 (2015) 128–136course format for university students. Importantly, while the core content
was similar, modiﬁcations to the length and number of lessons were
made during the trial based on the participants' feedback. Unfortunately,
while the present study is unable to provide any clear information about
treatment satisfaction and the optimum treatment formats for university
students, we believe that this is an important area for future research.
The present study was a small feasibility study and several impor-
tant limitations need to be considered when interpreting its ﬁndings.
First, although the ﬁndings are encouraging, the present study involvedTable 4
Proportions reporting reliable improvement and reliable recovery.
Clinical sample Post-treatment
Reliable
deterioration
χ2 No
change
χ2 Reliable
improvement
χ
PHQ-9 (PHQ-9 ≥ 10)
Treatment (n= 20) 0/20 – 8/20 χ2 = 5.0 7/20 χ
(0%) (40%) p= .03 (35%) p
Control (n= 11) 0/11 9/11 0/11
(0%) (82%) (0%)
GAD-7 (GAD-7 ≥ 8)
Treatment (n= 18) 0/18 χ2 = 6.9 4/18 χ2 = 4.0 6/18 χ
(0%) p= .01 (22%) p= .04 (33%) p
Control (n= 12) 4/12 7/12 1/12
(33%) (58%) (8%)
Note. A personwas deemed to havemade a reliable improvement if they scored above the total
deemed to have reliably recovered if they scored above the clinical cut-off at pre-treatment, m
or follow-up time point of interest. A personwas deemed to havemade a reliable deterioration
7-item. PHQ-9; Patient Health Questionnaire 9-item.a relatively small number of participants and consequently was under-
powered to detect small-to-moderate clinical effects. Thus, further con-
trolled trials withmuch larger samples are needed in the future. Second,
although there was evidence of further improvement in the treatment
group from post-treatment to 3-month follow-up, the use of a short
follow-up period and a waitlist-control group limits the conclusions
that can be made about long-term differences in clinical outcomes.
Third, the present study employed only clinical measures of anxiety
and depression and, while seeking assistance with their emotional3-Month follow-up
2 Reliable
recovery
χ2 Reliable
deterioration
No
change
Reliable
improvement
Reliable
recovery
2 = 5.0 5/20 χ2 = 0.2 0/20 2/20 0/20 18/20
= .03 (25%) p= .66 (0%) (10%) (10%) (90%)
2/11 – – – –
(18%)
2 = 2.5 8/18 χ2 = 7.3 0/18 2/18 2/18 14/18
= .11 (44%) p= .01 (0%) (11%) (11%) (78%)
0/12 – – – –
(0%)
cut-off at pre-treatment and their symptoms improved by a reliable amount. A personwas
ade a reliable improvement, and scored below the clinical cut-off at the post-treatment
if their symptoms deteriorated by a reliable amount. GAD-7; Generalised Anxiety Disorder
135A. Mullin et al. / Internet Interventions 2 (2015) 128–136wellbeing, many participants presented with subclinical level symp-
toms of anxiety and depression. Unfortunately, there is little clear guid-
ance about the most appropriate measures or outcomes in this area.
Similarly, the allocation of participants with MINI diagnoses was signif-
icantly different between groups and this is likely to have affected the
ﬁndings. Future studies may consider using stratiﬁed randomization
based on diagnosis to avoid this issue. Moreover, given that reductions
in levels of anxiety and depression are unlikely to be the most relevant
outcomes for all students, as observed in the present study, the inclu-
sion of general measures of coping and university performance would
be a worthwhile addition to future research. Fourth, based on partici-
pant feedback, several changesweremade to the treatment programme
during the current RCT in order to maximise acceptability, which may
have affected outcomes. Unfortunately, the small sample sizes partici-
pating in each version of the treatment programme mean that is not
possible to compare each version of the programme; however, further
research on the optimal structure of iCBT programmes for this popula-
tion would be valuable given the lower completion rates observed.
Finally, the present study employed a sample who were seeking and
willing to participate in an internet-delivered treatment programme,
rather than a more general student sample or students presenting
directly to a university counselling service. Consequently, some caution
is needed in generalising the results of the present study. However, a
large trial is currently underway exploring the implementation and
uptake, acceptability and efﬁcacy of iCBT provided as a part of routine
university counselling services.
In summary, no between-group differences were found in symp-
toms of anxiety and depression at post-treatment for the entire sample.
However, when focusing on students with clinical level symptoms, evi-
dences of signiﬁcant differences in symptoms of anxiety and depression
were obtained between the treatment and control groups at post-
treatment. The iCBT intervention required relatively little clinician
time per participant and was rated as acceptable by participants. Thus,
the present study provides preliminary support for the potential utility
of iCBT as an innovative approach for increasing access to and providing
psychological treatment for university students experiencing anxiety
and depression. Larger scale implementation trials with a broader
range of outcome measures are an important area for future research.Disclosures
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